← Eichor
Study identifier: NCT06670404 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Evaluation of Therapeutic Combination in Treating Vertebral Compression Fractures

Condition: Vertebral Compression Fractures · Pathological Fracture · Facet Joint Arthropathy  ·  Sponsor: Prof Nicolas Theumann

PhaseN/A
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to collect clinical and radiographic outcomes in patients undergoing vertebroplasty procedures for the treatment of osteoporotic or pathological fractures of the vertebral body to understand the role of sagittal balance in patient outcomes. To support this objective, the sagittal balance measurement of sagittal vertical axis (SVA), NRS back pain, Quebec Back Pain Disability Scale (Quebec) score, and complications will be collected. The secondary purpose of the study is to review the role of sagittal balance and adjacent facet joint arthropathy treatment in patients with vertebral body fractures due to osteoporosis or tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Nicolas Prof Theumann, Medical Doctor  ·  0041795251859  ·  nicolas.theumann@hirslanden.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Clinique Bois CerfLausanne, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06670404